Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
$229K Sell
7,384
-11,124
-60% -$378K 0.11% 102
2020
Q1
$572K Buy
18,508
+5,045
+37% +$172K 0.22% 70
2019
Q4
$500K Sell
13,463
-705
-5% -$25.1K 0.13% 75
2019
Q3
$483K Buy
14,168
+1,388
+11% +$50.5K 0.13% 82
2019
Q2
$525K Buy
12,780
+813
+7% +$32.3K 0.13% 78
2019
Q1
$481K Sell
11,967
-5,015
-30% -$201K 0.12% 90
2018
Q4
$704K Sell
16,982
-3,916
-19% -$163K 0.16% 67
2018
Q3
$841K Sell
20,898
-1,398
-6% -$53.8K 0.17% 63
2018
Q2
$768K Buy
22,296
+5,684
+34% +$194K 0.18% 65
2018
Q1
$560K Buy
16,612
+9,620
+138% +$331K 0.16% 61
2017
Q4
$240K Sell
6,992
-6,539
-48% -$223K 0.07% 65
2017
Q3
$457K Buy
13,531
+3,363
+33% +$108K 0.1% 71
2017
Q2
$323K Buy
10,168
+1,331
+15% +$42K 0.08% 68
2017
Q1
$285K Buy
+8,837
New +$279K 0.07% 64
2016
Q3
Sell
-6,480
Closed -$222K 78
2016
Q2
$222K Buy
6,480
+14
+0.2% +$447 0.07% 49
2016
Q1
$205K Buy
+6,466
New +$185K 0.07% 43

Other funds holding PFE

Private Vista's PFE Position: Q2 2020 in Review

Private Vista reduced its Pfizer (PFE) stake by 60% in Q2 2020, selling an estimated $378K and leaving 7,384 shares worth $229K. The position accounts for 0.11% of the portfolio, ranked #102.

Private Vista first reported a position in PFE in Q1 2016 and has held it in 16 quarters since. The position peaked at $841K in Q3 2018. 2,441 funds tracked by Wall St. Rank hold PFE as of Q2 2020.

  • Private Vista held 7,384 shares of Pfizer worth $229K as of Q2 2020.
  • Private Vista sold 11,124 Pfizer shares in Q2 2020, an estimated $378K.
  • Pfizer made up 0.11% of Private Vista's portfolio in Q2 2020, its #102 holding.
  • Private Vista first reported a position in Pfizer in Q1 2016 and has held it in 16 quarters since.
  • Private Vista's Pfizer position peaked at $841K in Q3 2018.
  • 2,441 funds tracked by Wall St. Rank held Pfizer as of Q2 2020.

Based on Private Vista's 13F filing for Q2 2020, filed 31 Jul 2020.